Literature DB >> 28202695

Distribution map of gadolinium deposition within the cerebellum following GBCA administration.

Donna R Roberts1, Cynthia A Welsh2, David P LeBel2, W Clay Davis2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28202695     DOI: 10.1212/WNL.0000000000003735

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  19 in total

Review 1.  The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists.

Authors:  Mariane Le Fur; Peter Caravan
Journal:  Metallomics       Date:  2019-02-20       Impact factor: 4.526

2.  Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation.

Authors:  A Luana Stanescu; Dennis W Shaw; Nozomu Murata; Kiyoko Murata; Joe C Rutledge; Ezekiel Maloney; Kenneth R Maravilla
Journal:  Pediatr Radiol       Date:  2020-01-27

3.  Absence of clinical cerebellar syndrome after serial injections of more than 20 doses of gadoterate, a macrocyclic GBCA: a monocenter retrospective study.

Authors:  Gaetano Perrotta; Thierry Metens; Julie Absil; Marc Lemort; Mario Manto
Journal:  J Neurol       Date:  2017-09-27       Impact factor: 4.849

4.  Post-marketing surveillance of gadobutrol for contrast-enhanced magnetic resonance imaging in Japan.

Authors:  Yoshito Tsushima; Kazuo Awai; Gen Shinoda; Hiroyuki Miyoshi; Masayuki Chosa; Toshiyuki Sunaya; Jan Endrikat
Journal:  Jpn J Radiol       Date:  2018-09-19       Impact factor: 2.374

5.  Reply to Radbruch et al.: 'interpreting signal-intensity ratios without visible T1 hyperintensities in clinical gadolinium retention studies'.

Authors:  Maria Camilla Rossi Espagnet; Paolo Tomà; Antonio Napolitano
Journal:  Pediatr Radiol       Date:  2017-09-07

6.  Reply to Lancelot et al.: 'Lack of evidence of a relationship between magnetic resonance signal intensity changes in the globus pallidus and dentate nucleus, and repeated administrations of gadoterate meglumine in children'.

Authors:  Maria Camilla Rossi Espagnet; Paolo Tomà; Antonio Napolitano
Journal:  Pediatr Radiol       Date:  2017-09-06

Review 7.  Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement.

Authors:  Carlo C Quattrocchi; Joana Ramalho; Aart J van der Molen; Àlex Rovira; Alexander Radbruch
Journal:  Eur Radiol       Date:  2018-11-09       Impact factor: 5.315

Review 8.  A Review of the Current Evidence on Gadolinium Deposition in the Brain.

Authors:  Richard Pullicino; Mark Radon; Shubhabrata Biswas; Maneesh Bhojak; Kumar Das
Journal:  Clin Neuroradiol       Date:  2018-03-09       Impact factor: 3.649

Review 9.  Is MRI imaging in pediatric age totally safe? A critical reprisal.

Authors:  Sergio Salerno; Claudio Granata; Marco Trapenese; Vittorio Cannata; Davide Curione; Maria Camilla Rossi Espagnet; Andrea Magistrelli; Paolo Tomà
Journal:  Radiol Med       Date:  2018-05-03       Impact factor: 3.469

10.  Dentate nucleus T1 hyperintensity: is it always gadolinium all that glitters?

Authors:  Luca Pasquini; Maria Camilla Rossi Espagnet; Antonio Napolitano; Daniela Longo; Alice Bertaina; Emiliano Visconti; Paolo Tomà
Journal:  Radiol Med       Date:  2018-01-27       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.